RIL
KNSA icon

Rothschild Investment LLC’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Rothschild Investment LLC’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Sell
166
-18
-10% -$934 ﹤0.01% 1846
2026
Q1 		$8.86K Buy
184
+24
+15% +$1.06K ﹤0.01% 1749
2025
Q4 		$6.6K Buy
160
+10
+7% +$401 ﹤0.01% 1745
2025
Q3 		$5.83K Buy
+150
New +$4.87K ﹤0.01% 1647

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rothschild Investment LLC's KNSA Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Kiniksa Pharmaceuticals (KNSA) stake by 9.8% in Q2 2026, selling an estimated $934 and leaving 166 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Rothschild Investment LLC first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Rothschild Investment LLC held 166 shares of Kiniksa Pharmaceuticals worth $10.6K as of Q2 2026.
  • Rothschild Investment LLC sold 18 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $934.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1846 holding.
  • Rothschild Investment LLC first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.